Accounting for Underspecification in Statistical Claims of Model Superiority
Thomas Sanchez, Pedro M. Gordaliza, Meritxell Bach Cuadra
TL;DR
This work addresses the risk that statistical claims of superiority in medical imaging are undermined by underspecification, i.e., seed-induced performance variance. It extends the Bayesian false-claim framework by adding an additive underspecification variance term, formalized as $SE^2_{AB,\text{underspec.}}$, and demonstrates this across segmentation (Dice Score Coefficient) and classification (AUROC) tasks. Using reproducibility-derived variability estimates, the authors show that even modest seed variability ($\delta \approx 0.01$) substantially raises the evidence required to claim superiority, increasing the probability of false outperformance when comparing models trained with different seeds. The study provides estimated parameter values ($s_{\text{seg}}=0.197$, $s_{\text{clf}}=0.737$) and argues for broader validation practices, including stress-testing across seeds and subgroups, to improve robustness of medical-imaging evaluations.
Abstract
Machine learning methods are increasingly applied in medical imaging, yet many reported improvements lack statistical robustness: recent works have highlighted that small but significant performance gains are highly likely to be false positives. However, these analyses do not take \emph{underspecification} into account -- the fact that models achieving similar validation scores may behave differently on unseen data due to random initialization or training dynamics. Here, we extend a recent statistical framework modeling false outperformance claims to include underspecification as an additional variance component. Our simulations demonstrate that even modest seed variability ($\sim1\%$) substantially increases the evidence required to support superiority claims. Our findings underscore the need for explicit modeling of training variance when validating medical imaging systems.
